Robeco Institutional Asset Management B.V. Repligen Corp Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $120,677 - $195,914	1,057 Added 271.03%	1,447 $260,000
Q4 2023 Feb 08, 2024	SELL	$114.17 - $185.35 $77,635 - $126,038	-680 Reduced 63.55%	390 $1.45 Million
Q3 2023 Oct 23, 2023	SELL	$138.78 - $176.51 $29,698 - $37,773	-214 Reduced 16.67%	1,070 $170,000
Q2 2023 Jul 24, 2023	BUY	$138.42 - $180.31 $11,073 - $14,424	80 Added 6.64%	1,284 $181,000
Q1 2023 May 03, 2023	SELL	$154.26 - $198.1 $226,145 - $290,414	-1,466 Reduced 54.91%	1,204 $202,000
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $433,661 - $588,895	2,670 New	2,670 $452,000
Q2 2022 Jul 27, 2022	SELL	$140.68 - $188.02 $7,596 - $10,153	-54 Closed	0 $0
Q1 2021 Dec 01, 2022	BUY	$180.37 - $226.26 $9,739 - $12,218	54 New	54 $10,000
Q1 2021 Apr 23, 2021	BUY	$180.37 - $226.26 $9,739 - $12,218	54 New	54 $10,000

Others Institutions Holding RGEN

# of Institutions

486

Shares Held

54.3M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.08 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$911 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$719 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$232 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$203 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account